It’s only fair to share… NXL-104, Avibactam trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt (e.g., NXL-104) CAS 396731-20-7, 1192491-61-4 AVE-1330 AVE-1330A PHASE 1 a broad-spectrum intravenous beta-lactamase inhibitor, was under development for the treatment of infections due to nosocomial drug resistant Gram-negative bacteria SANOFI INNOVATOR Novexel holds exclusive worldwide development and commercialization rights from Sanofi. NXL104; Avibactam; UNII-7352665165; Molecular Formula: C7H11N3O6S Molecular Weight: …